Great news. No additional drug development required.
I would suspect that the dosage was decided upon , in past trials, with this milestone in mind. Well done Dimerix. FA has just got better!
Ann: Adolescent Recruitment into ACTION3 Clinical Trial, page-11
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $239.5M | |||
| Open | High | Low | Value | Volume |
| 44.5¢ | 45.3¢ | 43.0¢ | $202.2K | 459.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 22830 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 23049 | 3 |
View Market Depth
| Last trade - 13.04pm 20/08/2024 (20 minute delay) ? |
| DXB (ASX) Chart |